Type
. The image of a leper (?): a paradigm of hidden fears of contagious diseases (exemplified in a wall painting of Saint Elizabeth of Hungary). Journal of the European Academy of Dermatology and Venereology : JEADV. 2002;16(5):447-9.
Type
. Differential TNFalpha mRNA regulation detected in the epidermis of leprosy patients. Archives of dermatological research. 2002;294(8):355-62.
Type
. [A 50-year history of new drugs in Japan: the developments of antileprosy drugs and their epidemiological aspects]. Yakushigaku zasshi. 2002;37(1):76-83.
Type
The US-Japan Cooperative Medical Science Program Tuberculosis and Leprosy Panel's 36th Annual Research Conference, New Orleans, Louisiana, USA, 15-17 July 2001. Abstracts. Tuberculosis (Edinburgh, Scotland). 2002;82(2-3):113-35.
Type
. A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions. The Journal of infectious diseases [Internet]. 2002;186(9):1283-96. Available from: https://academic.oup.com/jid/article-lookup/doi/10.1086/344313
Type
. Leprosy in a high-prevalence Egyptian village: epidemiology and risk factors. International journal of dermatology. 2002;41(10):681-6.
Type
. Haematological alterations in leprosy patients treated with dapsone. East African medical journal. 2002;79(2):100-2.
Type
. Thalidomide in the treatment of leprosy. Microbes and infection. 2002;4(11):1193-202.
Type
New tools for leprosy control. TDR news. 1998;(55):4.
Type
. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients. Clinical and experimental immunology [Internet]. 1989;78(2):214-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1534668/pdf/clinexpimmunol00080-0074.pdf